Latest News

The Wall Street Journal: Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market

0

Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.

The talks have been going on for a while, but any agreement isn’t likely for another few weeks or more — and there may not be one.

Down More Than 60%: Analysts Say Buy These 3 Beaten-Down Stocks Before They Rebound

Previous article

: Tim Ryan and J.D. Vance spar over approach to China during first of two Senate debates in Ohio

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News